Atlas Trials

Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer

Clinical trial NCT03622827 · UNKNOWN

Trial details

NCT number
NCT03622827
Sponsor
Nanjing Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Uterine Cervical Neoplasms
Start date
2018-07-31
Primary completion
2023-07-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.